163 related articles for article (PubMed ID: 15286159)
1. Polymorphisms in the mannose binding lectin gene affect the cystic fibrosis pulmonary phenotype.
Yarden J; Radojkovic D; De Boeck K; Macek M; Zemkova D; Vavrova V; Vlietinck R; Cassiman JJ; Cuppens H
J Med Genet; 2004 Aug; 41(8):629-33. PubMed ID: 15286159
[No Abstract] [Full Text] [Related]
2. An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study.
Tomaiuolo R; Degiorgio D; Coviello DA; Baccarelli A; Elce A; Raia V; Motta V; Seia M; Castaldo G; Colombo C
Dig Liver Dis; 2009 Nov; 41(11):817-22. PubMed ID: 19467940
[TBL] [Abstract][Full Text] [Related]
3. Mannose-binding lectin gene as a modifier of the cystic fibrosis phenotype in Argentinean pediatric patients.
Gravina LP; Crespo C; Giugno H; Sen L; Chertkoff L; Mangano A; Castaños C
J Cyst Fibros; 2015 Jan; 14(1):78-83. PubMed ID: 25178872
[TBL] [Abstract][Full Text] [Related]
4. MBL2 polymorphisms screening in a regional Italian CF Center.
Trevisiol C; Boniotto M; Giglio L; Poli F; Morgutti M; Crovella S
J Cyst Fibros; 2005 Sep; 4(3):189-91. PubMed ID: 16046196
[TBL] [Abstract][Full Text] [Related]
5. [Modifier genes and cystic fibrosis].
Corvol H; Flamant C; Vallet C; Clement A; Brouard J
Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
[TBL] [Abstract][Full Text] [Related]
6. Modifier genes in cystic fibrosis.
Davies JC; Griesenbach U; Alton E
Pediatr Pulmonol; 2005 May; 39(5):383-91. PubMed ID: 15765543
[TBL] [Abstract][Full Text] [Related]
7. Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis.
Urquhart DS; Allen J; Elrayess M; Fidler K; Klein N; Jaffé A
Arch Immunol Ther Exp (Warsz); 2006; 54(4):271-6. PubMed ID: 16830219
[TBL] [Abstract][Full Text] [Related]
8. Airway plumbing.
Hanrahan JW
J Clin Invest; 2000 May; 105(10):1343-4. PubMed ID: 10811841
[No Abstract] [Full Text] [Related]
9. Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis.
Derichs N; Schuster A; Grund I; Ernsting A; Stolpe C; Körtge-Jung S; Gallati S; Stuhrmann M; Kozlowski P; Ballmann M
Clin Genet; 2005 Jun; 67(6):529-31. PubMed ID: 15857421
[No Abstract] [Full Text] [Related]
10. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
11. Gene modifiers in cystic fibrosis.
Accurso FJ; Sontag MK
J Clin Invest; 2008 Mar; 118(3):839-41. PubMed ID: 18292812
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis in a boy with meconium ileus and mild clinical phenotype associated with 2183AA-G/D1152H genotype.
Yalçin E; Ozçelik U; Yilmaz E; Doğru D; Kiper N; Ferec C
Turk J Pediatr; 2008; 50(4):383-5. PubMed ID: 19014055
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in cystic fibrosis airway inflammation.
Puchelle E; De Bentzmann S; Hubeau C; Jacquot J; Gaillard D
Pediatr Pulmonol; 2001; Suppl 23():143-5. PubMed ID: 11886121
[No Abstract] [Full Text] [Related]
14. Nonclassic cystic fibrosis: a clinical conundrum.
Rosenstein BJ
Pediatr Pulmonol; 2003 Jul; 36(1):10-2. PubMed ID: 12772217
[No Abstract] [Full Text] [Related]
15. [Challenges of genetic diseases. About a genetic disease: cystic fibrosis].
Labrune P
Rev Prat; 2002 Mar; 52(6):679-82. PubMed ID: 12001420
[No Abstract] [Full Text] [Related]
16. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
17. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ
Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis: a further case of an asymptomatic compound heterozygote.
White SM; Lucassen A; Norbury G
Am J Med Genet; 2001 Nov; 103(4):342-3. PubMed ID: 11746017
[No Abstract] [Full Text] [Related]
19. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM
Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
Mussaffi H; Prais D; Mei-Zahav M; Blau H
Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
